newsOcrelizumab reccommended for relapsing remitting multiple sclerosis10 December 2018 | By European Pharmaceutical ReviewOcrelizumab has been recommended by the Scottish Medicines Consortium to treat relapsing remitting multiple sclerosis (RRMS) in adults.
newsEuropean Commission approves ocrelizumab for RMS and PPMS12 January 2018 | By Dr Zara Kassam (European Pharmaceutical Review)Ocrelizumab provides a new treatment option for adults with active relapsing forms of multiple sclerosis...